Prednisone, Lupus Activity, and Permanent Organ Damage
- 4 February 2009
- journal article
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 36 (3), 560-564
- https://doi.org/10.3899/jrheum.080828
Abstract
Objective.To estimate the effect of corticosteroids (prednisone dose) on permanent organ damage among persons with systemic lupus erythematosus (SLE).Methods.We identified 525 patients with incident SLE in the Hopkins Lupus Cohort. At each visit, clinical activity indices, laboratory data, and treatment were recorded. The study population was followed from the month after the first visit until June 29, 2006, or attainment of irreversible organ damage, death, loss to follow-up, or receipt of pulse methylprednisolone therapy. We estimated the effect of cumulative average dose of prednisone on organ damage using a marginal structural model to adjust for time-dependent confounding by indication due to SLE disease activity.Results.Compared with non-prednisone use, the hazard ratio of organ damage for prednisone was 1.16 (95% CI 0.54, 2.50) for cumulative average doses > 0–180 mg/month, 1.50 (95% CI 0.58, 3.88) for > 180–360 mg/month, 1.64 (95% CI 0.58, 4.69) for > 360–540 mg/month, and 2.51 (95% CI 0.87, 7.27) for > 540 mg/month. In contrast, standard Cox regression models estimated higher hazard ratios at all dose levels.Conclusion.Our results suggest that low doses of prednisone do not result in a substantially increased risk of irreversible organ damage.Keywords
This publication has 21 references indexed in Scilit:
- Lupus in Baltimore: evidence-based ‘clinical pearls’ from the Hopkins Lupus CohortLupus, 2005
- New therapies for systemic lupus erythematosusClinical and Experimental Immunology, 2005
- Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXII. Predictors of time to the occurrence of initial damageArthritis & Rheumatism, 2004
- Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measuresStatistics in Medicine, 2002
- Marginal Structural Models to Estimate the Joint Causal Effect of Nonrandomized TreatmentsJournal of the American Statistical Association, 2001
- HOPKINS LUPUS COHORT: 1999 UpdateRheumatic Disease Clinics of North America, 2000
- The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index in patients with Systemic Lupus ErythematosusArthritis & Rheumatism, 1997
- The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosusArthritis & Rheumatism, 1997
- The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosusArthritis & Rheumatism, 1996
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992